Stellar Biotechnologies Presents KLH Verification Method at Aquaculture America Conference
12 févr. 2014 09h05 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Feb 12, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today the presentation of a poster at...
Bionor Pharma's Phase II Vacc-4x Data Published in the Lancet Infectious Diseases
11 févr. 2014 09h27 HE
|
Bionor Pharma
OSLO, NORWAY--(Marketwired - Feb 11, 2014) - Bionor Pharma ASA (OSE: BIONOR) announces that the results from the randomized, multicenter, double-blinded, placebo-controlled Phase II trial with 135...
Hemispherx Biopharma Reports Evidence Based Clinical Potential of a Natural Interferon (IFN) -- Alpha for Infection Control and Treatment of Drug Resistant H7N9 Influenza Virus
07 janv. 2014 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") today announced publication of an article entitled "Emergence of a novel drug...
Stellar Biotechnologies, Inc. to Present at Two Investor Conferences in January
06 janv. 2014 09h05 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Jan 6, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that the Company will present at two...
Stellar Biotechnologies Issues Year-End Results and Highlights From 2013
02 janv. 2014 09h05 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Jan 2, 2014) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today the filing of its annual report for the...
Stellar Biotechnologies, Inc. Announces Meeting and Record Date and Approval of Advance Notice Policy
27 déc. 2013 16h00 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Dec 27, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that it will hold an annual general and...
Centers for Disease Control Urges Preparation for an Active Seasonal Flu Season
16 déc. 2013 08h30 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Dec. 16, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announced that the company will accelerate its experimental program for a new...
Stellar Biotechnologies Announces Collaboration With Amaran Biotechnology, Inc.
12 déc. 2013 12h01 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Dec 12, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that it has entered into a...
Stellar Biotechnologies Announces Patents for Clostridium Difficile Immunotherapy Technology Issued in U.S. and China
09 déc. 2013 09h05 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Dec 9, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of Keyhole...
Stellar Biotechnologies to Host Corporate Update Conference Call and Webcast on December 11
03 déc. 2013 09h05 HE
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Dec 3, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of Keyhole...